{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T11:46:16Z","timestamp":1750938376921,"version":"3.41.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100008804","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST 111-2314-B-016-047-MY3"],"award-info":[{"award-number":["MOST 111-2314-B-016-047-MY3"]}],"id":[{"id":"10.13039\/501100008804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Sodium\u2013glucose cotransporter-2 inhibitors (SGLT2i), a novel class of antidiabetic medication, have emerged as a key treatment option in diabetes management. Notably, SGLT2i promote glucose and sodium excretion through urine, a mechanism that may be implicated in the potential association between SGLT2i use and risk of atopic dermatitis (AD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To investigate the relationship between SGLT2i use and new-onset AD in people with diabetes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This nationwide active-comparator cohort study used data from the Taiwan National Health Insurance database to investigate the association between SGLT2i use and AD risk. The study included adults with type 2 diabetes mellitus who initiated SGLT2i or DPP4i between May 2016 and December 2018, with no prescriptions for other SGLT2i or DPP4i in the 12\u2005months prior to cohort entry. A total of 148 354 SGLT2i users were identified as the study group, while 322 703 DPP4i users were designated as the active comparator group. The primary outcome was the incidence of AD. To minimize potential confounding, inverse probability of treatment weighting (IPTW) was applied to balance baseline characteristics, medical history and ever having used medication between the two groups. Additionally, sensitivity analyses, subgroup analyses and sex-specific assessments were conducted to further validate the findings. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the risk of developing AD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>SGLT2i users had a lower incidence of AD (9.742 vs. 12.070 per 1000 PY) than DPP4i users. SGLT2i users had a significantly lower risk of AD compared with DPP4i users (HR 0.847) after IPTW adjustment. Different types of SGLT2i also showed a consistent protective effect for AD. Notably, the highest SGLT2i dosage was associated with the lowest risk of AD (IPTW-adjusted HR 0.647), consistent across sensitivity analyses. Additionally, men who use SGLT2i exhibited a much lower risk of AD (IPTW-adjusted HR 0.750) than women who use SGLT2i.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>SGLT2i show a significant protective effect against AD in patients with diabetes compared with DPP4i. This robust finding, consistent across weighting and sensitivity analyses, supports SGLT2i use, with a strong protective effect also found in the dose\u2013response analysis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjd\/ljaf086","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T01:41:36Z","timestamp":1741138896000},"page":"74-84","source":"Crossref","is-referenced-by-count":1,"title":["Sodium\u2013glucose cotransporter 2 inhibitors and inverse risk of new-onset atopic dermatitis in a cohort with diabetes: a nationwide active-comparator study"],"prefix":"10.1093","volume":"193","author":[{"given":"Yuan-Liang","family":"Wen","sequence":"first","affiliation":[{"name":"School of Pharmacy, National Defense Medical Center , Taipei ,","place":["Taiwan"]},{"name":"Graduate Institute of Life Sciences, National Defense Medical Center , Taipei ,","place":["Taiwan"]},{"name":"School of Public Health, National Defense Medical Center , Taipei ,","place":["Taiwan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Ting","family":"Hsu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, National Defense Medical Center , Taipei ,","place":["Taiwan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Hsien","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Tri-Service General Hospital, National Defense Medical Center , Taipei ,","place":["Taiwan"]},{"name":"Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University , Taipei ,","place":["Taiwan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Han","family":"Kao","sequence":"additional","affiliation":[{"name":"School of Public Health, National Defense Medical Center , Taipei ,","place":["Taiwan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Cheng","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Taichung Armed Forces General Hospital , Taichung ,","place":["Taiwan"]},{"name":"Department of Medical Education and Research, Taichung Armed Forces General Hospital , Taichung ,","place":["Taiwan"]},{"name":"School of Medicine, National Defense Medical Center , Taipei ,","place":["Taiwan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Yin","family":"To","sequence":"additional","affiliation":[{"name":"School of Pharmacy, National Defense Medical Center , Taipei ,","place":["Taiwan"]},{"name":"Graduate Institute of Life Sciences, National Defense Medical Center , Taipei ,","place":["Taiwan"]},{"name":"School of Public Health, National Defense Medical Center , Taipei ,","place":["Taiwan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Wen","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, National Defense Medical Center , Taipei ,","place":["Taiwan"]},{"name":"Graduate Institute of Life Sciences, National Defense Medical Center , Taipei ,","place":["Taiwan"]},{"name":"School of Public Health, National Defense Medical Center , Taipei ,","place":["Taiwan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0692-7408","authenticated-orcid":false,"given":"Li-Ting","family":"Kao","sequence":"additional","affiliation":[{"name":"School of Pharmacy, National Defense Medical Center , Taipei ,","place":["Taiwan"]},{"name":"Graduate Institute of Life Sciences, National Defense Medical Center , Taipei ,","place":["Taiwan"]},{"name":"Department of Pharmacy Practice, Tri-Service General Hospital , Taipei ,","place":["Taiwan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"2025062500103221000_ljaf086-B1","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41574-021-00512-2","article-title":"Type 2 diabetes mellitus in older adults: clinical considerations and management","volume":"17","author":"Bellary","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"2025062500103221000_ljaf086-B2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0140-6736(14)60648-6","article-title":"Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA","volume":"384","author":"Bauer","year":"2014","journal-title":"Lancet"},{"key":"2025062500103221000_ljaf086-B3","doi-asserted-by":"crossref","first-page":"e022768","DOI":"10.1136\/bmjopen-2018-022768","article-title":"Changing use of antidiabetic drugs in the UK: trends in prescribing 2000\u20132017","volume":"8","author":"Wilkinson","year":"2018","journal-title":"BMJ Open"},{"key":"2025062500103221000_ljaf086-B4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-physiol-031620-095920","article-title":"Effects of SGLT2 inhibitors on kidney and cardiovascular function","volume":"83","author":"Vallon","year":"2021","journal-title":"Ann Rev Physiol"},{"key":"2025062500103221000_ljaf086-B5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-med-042921-102135","article-title":"SGLT2 inhibitors: the sweet success for kidneys","volume":"74","author":"Dharia","year":"2023","journal-title":"Annu Rev Med"},{"key":"2025062500103221000_ljaf086-B6","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/obr.12755","article-title":"Weight loss associated with sodium\u2013glucose cotransporter-2 inhibition: a review of evidence and underlying mechanisms","volume":"19","author":"Lee","year":"2018","journal-title":"Obes Rev"},{"key":"2025062500103221000_ljaf086-B7","doi-asserted-by":"crossref","first-page":"e5650","DOI":"10.1097\/MD.0000000000005650","article-title":"Increased risk of stroke in contact dermatitis patients: a nationwide population-based retrospective cohort study","volume":"96","author":"Chang","year":"2017","journal-title":"Medicine"},{"key":"2025062500103221000_ljaf086-B8","doi-asserted-by":"crossref","first-page":"e018091","DOI":"10.1136\/bmjopen-2017-018091","article-title":"Risks for comorbidity in children with atopic disorders: an observational study in Dutch general practices","volume":"7","author":"Pols","year":"2017","journal-title":"BMJ Open"},{"key":"2025062500103221000_ljaf086-B9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jaad.2017.04.019","article-title":"Impact of atopic dermatitis on health-related quality of life and productivity in adults in the United States: an analysis using the National Health and Wellness Survey","volume":"77","author":"Eckert","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"2025062500103221000_ljaf086-B10","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","article-title":"Atopic dermatitis","volume":"387","author":"Weidinger","year":"2016","journal-title":"Lancet"},{"key":"2025062500103221000_ljaf086-B11","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaci.2014.11.023","article-title":"Eczema and cardiovascular risk factors in 2 US adult population studies","volume":"135","author":"Silverberg","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2025062500103221000_ljaf086-B12","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/pai.12095","article-title":"Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization","volume":"24","author":"Silverberg","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"key":"2025062500103221000_ljaf086-B13","first-page":"e13750","article-title":"The cross-talk between atopic dermatitis and diabetes mellitus: a meta-analysis","volume":"13","author":"Mirghani","year":"2021","journal-title":"Cureus"},{"key":"2025062500103221000_ljaf086-B14","doi-asserted-by":"crossref","first-page":"eaau0683","DOI":"10.1126\/scitranslmed.aau0683","article-title":"Sodium chloride is an ionic checkpoint for human TH2 cells and shapes the atopic skin microenvironment","volume":"11","author":"Matthias","year":"2019","journal-title":"Sci Transl Med"},{"key":"2025062500103221000_ljaf086-B15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.alit.2018.06.003","article-title":"Sweat in the pathogenesis of atopic dermatitis","volume":"67","author":"Murota","year":"2018","journal-title":"Allergol Int"},{"key":"2025062500103221000_ljaf086-B16","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41374-020-0371-1","article-title":"Knockdown of sodium channel Nax reduces dermatitis symptoms in rabbit skin","volume":"100","author":"Zhao","year":"2020","journal-title":"Lab Invest"},{"key":"2025062500103221000_ljaf086-B17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41581-020-00350-x","article-title":"Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation","volume":"17","author":"Marton","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"2025062500103221000_ljaf086-B18","doi-asserted-by":"crossref","first-page":"e0195960","DOI":"10.1371\/journal.pone.0195960","article-title":"Sweat glucose and GLUT2 expression in atopic dermatitis: Implication for clinical manifestation and treatment","volume":"13","author":"Ono","year":"2018","journal-title":"PLOS ONE"},{"key":"2025062500103221000_ljaf086-B19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11192-010-0289-2","article-title":"Taiwan\u2019s National Health Insurance Research Database: administrative health care database as study object in bibliometrics","volume":"86","author":"Chen","year":"2011","journal-title":"Scientometrics"},{"key":"2025062500103221000_ljaf086-B20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/pds.5407","article-title":"Core concepts in pharmacoepidemiology: confounding by indication and the role of active comparators","volume":"31","author":"Sendor","year":"2022","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2025062500103221000_ljaf086-B21","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.jfma.2022.01.028","article-title":"Healthcare utilization and costs of atopic dermatitis in Taiwan","volume":"121","author":"Lee","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"2025062500103221000_ljaf086-B22","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/jamadermatol.2023.1300","article-title":"Risk of venous thromboembolism among adults with atopic dermatitis","volume":"159","author":"Chen","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"Suppl. 1","key":"2025062500103221000_ljaf086-B23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000370220","article-title":"Atopic dermatitis: global epidemiology and risk factors","volume":"66","author":"Nutten","year":"2015","journal-title":"Ann Nutr Metab"},{"key":"2025062500103221000_ljaf086-B24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/bjd.20661","article-title":"Association between atopic dermatitis and hypertension: a systematic review and meta-analysis","volume":"186","author":"Yousaf","year":"2022","journal-title":"Br J Dermatol"},{"key":"2025062500103221000_ljaf086-B25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/pde.15502","article-title":"Increased prevalence of metabolic syndrome and non-alcoholic fatty liver disease in children with atopic dermatitis: a case\u2013control study from northern India","volume":"41","author":"Reddy","year":"2024","journal-title":"Pediatr Dermatol"},{"key":"2025062500103221000_ljaf086-B26","doi-asserted-by":"crossref","first-page":"1180596","DOI":"10.3389\/fmed.2023.1180596","article-title":"Atopic dermatitis and chronic kidney disease: a bidirectional Mendelian randomization study","volume":"10","author":"Zhang","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"2025062500103221000_ljaf086-B27","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/all.12685","article-title":"Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studies","volume":"70","author":"Silverberg","year":"2015","journal-title":"Allergy"},{"key":"2025062500103221000_ljaf086-B28","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.jaad.2019.08.039","article-title":"Atopic dermatitis and risk of atrial fibrillation or flutter: a 35-year follow-up study","volume":"83","author":"Schmidt","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2025062500103221000_ljaf086-B29","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/bjd\/ljac132","article-title":"Factors associated with depression, anxiety and severe mental illness among adults with atopic eczema or psoriasis: a systematic review and meta-analysis","volume":"188","author":"Adesanya","year":"2023","journal-title":"Br J Dermatol"},{"key":"2025062500103221000_ljaf086-B30","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jaad.2016.08.047","article-title":"Autoimmune diseases in adults with atopic dermatitis","volume":"76","author":"Andersen","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"2025062500103221000_ljaf086-B31","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/jdv.14814","article-title":"Atopic dermatitis and alcohol use \u2013 a meta-analysis and systematic review","volume":"32","author":"Halling-Overgaard","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025062500103221000_ljaf086-B32","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.jdiacomp.2016.08.002","article-title":"Possible new inflammatory side-effect of SGLT2-inhibitors: fixed drug eruption","volume":"30","author":"Damiani","year":"2016","journal-title":"J Diabetes Complications"},{"key":"2025062500103221000_ljaf086-B33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1574886311666160405110515","article-title":"Generalized intense pruritus during canagliflozin treatment: is it an adverse drug reaction?","volume":"13","author":"Vasapollo","year":"2018","journal-title":"Current Drug Safety"},{"key":"2025062500103221000_ljaf086-B34","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1185\/03007995.2012.697053","article-title":"Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor","volume":"28","author":"Nyirjesy","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"2025062500103221000_ljaf086-B35","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/ijd.12883","article-title":"T-helper 22 cells as a new player in chronic inflammatory skin disorders","volume":"54","author":"Mirshafiey","year":"2015","journal-title":"Int J Dermatol"},{"key":"2025062500103221000_ljaf086-B36","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12920-023-01575-y","article-title":"Mendelian randomization indicates that atopic dermatitis contributes to the occurrence of diabetes","volume":"16","author":"Lu","year":"2023","journal-title":"BMC Med Genomics"},{"key":"2025062500103221000_ljaf086-B37","doi-asserted-by":"crossref","first-page":"e15116","DOI":"10.1111\/exd.15116","article-title":"Interplay between diabetes mellitus and atopic dermatitis","volume":"33","author":"Lei","year":"2024","journal-title":"Exp Dermatol"},{"key":"2025062500103221000_ljaf086-B38","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra2023911","article-title":"Atopic dermatitis","volume":"384","author":"St\u00e4nder","year":"2021","journal-title":"N Engl J Med"},{"key":"2025062500103221000_ljaf086-B39","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","article-title":"Atopic dermatitis","volume":"396","author":"Langan","year":"2020","journal-title":"Lancet"},{"key":"2025062500103221000_ljaf086-B40","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tim.2017.11.008","article-title":"Staphylococcus aureus and atopic dermatitis: a complex and evolving relationship","volume":"26","author":"Geoghegan","year":"2018","journal-title":"Trends Microbiol"},{"key":"2025062500103221000_ljaf086-B41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/jb.88.1.1-3.1964","article-title":"Tolerance of Staphylococcus aureus to sodium chloride","volume":"88","author":"Parfentjev","year":"1964","journal-title":"J Bacteriol"},{"key":"2025062500103221000_ljaf086-B42","doi-asserted-by":"crossref","first-page":"eaal4651","DOI":"10.1126\/scitranslmed.aal4651","article-title":"Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis","volume":"9","author":"Byrd","year":"2017","journal-title":"Sci Transl Med"},{"key":"2025062500103221000_ljaf086-B43","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jdiacomp.2019.04.006","article-title":"Tissue sodium content in patients with type 2 diabetes mellitus","volume":"33","author":"Kannenkeril","year":"2019","journal-title":"J Diabetes Complications"},{"key":"2025062500103221000_ljaf086-B44","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/HYPERTENSIONAHA.119.11684","article-title":"Antihypertensive and renal mechanisms of SGLT2 (sodium\u2013glucose linked transporter 2) inhibitors","volume":"75","author":"Wilcox","year":"2020","journal-title":"Hypertension"},{"key":"2025062500103221000_ljaf086-B45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12933-017-0654-z","article-title":"SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial","volume":"17","author":"Karg","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"2025062500103221000_ljaf086-B46","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1550-8579(07)80061-1","article-title":"Gender differences in skin: a review of the literature","volume":"4","author":"Dao","year":"2007","journal-title":"Gend Med"},{"key":"2025062500103221000_ljaf086-B47","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.3390\/ijms20194660","article-title":"The roles of sex hormones in the course of atopic dermatitis","volume":"20","author":"Kanda","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2025062500103221000_ljaf086-B48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1550-8579(04)80017-2","article-title":"Does visible atopic dermatitis affect quality of life more in women than in men?","volume":"1","author":"Holm","year":"2004","journal-title":"Gend Med"},{"key":"2025062500103221000_ljaf086-B49","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/17512433.2022.2055546","article-title":"Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic review","volume":"15","author":"Gembillo","year":"2022","journal-title":"Expert Rev Clin Pharmacol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf086\/62263902\/ljaf086.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/193\/1\/74\/62263902\/ljaf086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/193\/1\/74\/62263902\/ljaf086.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T04:10:43Z","timestamp":1750824643000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/193\/1\/74\/8051637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3,4]]},"published-print":{"date-parts":[[2025,6,20]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf086","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"type":"print","value":"0007-0963"},{"type":"electronic","value":"1365-2133"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,3,4]]}}}